• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌相关的微小RNA与单核苷酸多态性:孟德尔随机化分析

The Lung Cancer Associated MicroRNAs and Single Nucleotides Polymorphisms: a Mendelian Randomization Analysis.

作者信息

Huang Ruixuan, Cho William C, Sun Yanni, Katie Chan Kei Hang

出版信息

Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:2346-2352. doi: 10.1109/EMBC44109.2020.9176344.

DOI:10.1109/EMBC44109.2020.9176344
PMID:33018478
Abstract

Lung cancer is a major public health burden and among the highest incidence and mortality rates of the cancers. MicroRNAs (miRNAs) play an important role in the development of lung cancer. The aim of this study was to investigate whether there was a potential causal relation between miRNAs and non-small-cell lung cancer (NSCLC). 1,026 patients with NSCLC from The Cancer Genome Atlas (TCGA) were analyzed. NSCLC associated SNPs' allele scores were established, and candidate miRNAs were filtered from differential expression analysis. Mendelian randomization (MR) analysis was conducted for 5 candidate miRNA (hsa-miR-135b, hsa-miR-142, hsa-miR-182, hsa-miR-183 and hsa-miR-3607) and 76 candidate SNPs in lung adenocarcinoma (LUAD) group. According to the core assumptions of MR, there was no clear evidence of a causal relation between the 5 candidate miRNAs and LUAD. The reads per million miRNAs mapped (RPM) level of candidate miRNAs changed less than 3% per allele score. To our knowledge, this is the first study using the TCGA data set to investigate the causal relation between miRNAs and lung cancer using the MR approach, and also one of the first MR studies to use miRNA expression as an exposure factor, with the SNPs as instrumental variables.

摘要

肺癌是一项重大的公共卫生负担,在各类癌症中发病率和死亡率位居前列。微小RNA(miRNA)在肺癌发展过程中发挥着重要作用。本研究旨在调查miRNA与非小细胞肺癌(NSCLC)之间是否存在潜在因果关系。对来自癌症基因组图谱(TCGA)的1026例NSCLC患者进行了分析。建立了与NSCLC相关的单核苷酸多态性(SNP)的等位基因评分,并通过差异表达分析筛选出候选miRNA。对肺腺癌(LUAD)组中的5个候选miRNA(hsa-miR-135b、hsa-miR-142、hsa-miR-182、hsa-miR-183和hsa-miR-3607)和76个候选SNP进行了孟德尔随机化(MR)分析。根据MR的核心假设,没有明确证据表明这5个候选miRNA与LUAD之间存在因果关系。每个等位基因评分中,候选miRNA的每百万映射miRNA读数(RPM)水平变化小于3%。据我们所知,这是第一项使用TCGA数据集通过MR方法研究miRNA与肺癌之间因果关系的研究,也是最早将miRNA表达作为暴露因素、以SNP作为工具变量的MR研究之一。

相似文献

1
The Lung Cancer Associated MicroRNAs and Single Nucleotides Polymorphisms: a Mendelian Randomization Analysis.肺癌相关的微小RNA与单核苷酸多态性:孟德尔随机化分析
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:2346-2352. doi: 10.1109/EMBC44109.2020.9176344.
2
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.使用 microRNA 测序技术分析耐药非小细胞肺癌细胞系中 microRNA 的表达谱
Cell Physiol Biochem. 2018;51(6):2509-2522. doi: 10.1159/000495921. Epub 2018 Dec 17.
3
Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.分析 microRNA(miRNA)表达谱揭示了与非小细胞肺癌相关的 11 个关键生物标志物。
World J Surg Oncol. 2017 Sep 19;15(1):175. doi: 10.1186/s12957-017-1244-y.
4
Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.血浆微小RNA在预测非小细胞肺癌放射敏感性中的作用
Tumour Biol. 2016 Sep;37(9):11927-11936. doi: 10.1007/s13277-016-5052-8. Epub 2016 Apr 13.
5
Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.利用 miRNA 表达谱鉴定肺腺癌患者生存时间相关的 miRNA 特征。
Sci Rep. 2017 Aug 8;7(1):7507. doi: 10.1038/s41598-017-07739-y.
6
Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.鉴定三个差异表达的 miRNA 作为肺腺癌预后的潜在生物标志物。
Comb Chem High Throughput Screen. 2020;23(2):148-156. doi: 10.2174/1386207323666200124123103.
7
Clinical evaluation of microRNA expression profiling in non small cell lung cancer.非小细胞肺癌中 microRNA 表达谱的临床评估。
Lung Cancer. 2013 Sep;81(3):388-396. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.
8
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.肿瘤抑制因子hsa-miR-145的恢复可抑制表皮生长因子受体突变的肺腺癌患者的癌细胞生长。
Eur J Cancer. 2009 Aug;45(12):2197-206. doi: 10.1016/j.ejca.2009.04.039. Epub 2009 Jun 1.
9
Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.鉴定九个 microRNAs 作为肺腺癌的潜在生物标志物。
FEBS Open Bio. 2019 Jan 9;9(2):315-327. doi: 10.1002/2211-5463.12572. eCollection 2019 Feb.
10
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.循环外泌体微小RNA作为非小细胞肺癌的预后生物标志物
Oncotarget. 2017 Feb 21;8(8):13048-13058. doi: 10.18632/oncotarget.14369.

引用本文的文献

1
Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma.探索CX3CR1作为肉瘤的预后生物标志物和免疫治疗靶点。
Transl Oncol. 2025 Mar;53:102283. doi: 10.1016/j.tranon.2025.102283. Epub 2025 Jan 20.
2
Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson's disease.全基因组范围内的系统孟德尔随机化研究揭示了微小RNA与帕金森病之间的因果关系。
Front Neurosci. 2024 May 3;18:1385675. doi: 10.3389/fnins.2024.1385675. eCollection 2024.
3
Transcriptional expressions of hsa-mir-183 predicted target genes as independent indicators for prognosis in bladder urothelial carcinoma.
hsa-mir-183 预测靶基因的转录表达作为膀胱癌的独立预后指标。
Aging (Albany NY). 2022 May 3;14(9):3782-3800. doi: 10.18632/aging.204040.
4
Systematic review of Mendelian randomization studies on risk of cancer.癌症风险的孟德尔随机化研究系统综述。
BMC Med. 2022 Feb 2;20(1):41. doi: 10.1186/s12916-022-02246-y.